Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 406898
MIM: 300812
HGNC: 31493
Ensembl: ENSG00000207818
miRBase:
Variants:
dbSNP: 406898
ClinVar: 406898
TCGA: ENSG00000207818
COSMIC: MIR105-2
RNA/Proteins
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 33345445 | 2021 | Cancer-secreted miRNAs regulate amino-acid-induced mTORC1 signaling and fibroblast protein synthesis. | 17 |
| 33722196 | 2021 | MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4. | 9 |
| 33838353 | 2021 | MiR-105 enhances osteogenic differentiation of hADSCs via the targeted regulation of SOX9. | 1 |
| 33846814 | 2021 | Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer. | 8 |
| 33345445 | 2021 | Cancer-secreted miRNAs regulate amino-acid-induced mTORC1 signaling and fibroblast protein synthesis. | 17 |
| 33722196 | 2021 | MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4. | 9 |
| 33838353 | 2021 | MiR-105 enhances osteogenic differentiation of hADSCs via the targeted regulation of SOX9. | 1 |
| 33846814 | 2021 | Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer. | 8 |
| 31796663 | 2020 | MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene. | 11 |
| 31796663 | 2020 | MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene. | 11 |
| 31115004 | 2019 | Up-regulation of miRNA-105 inhibits the progression of gastric carcinoma by directly targeting SOX9. | 3 |
| 31364116 | 2019 | MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9. | 10 |
| 31115004 | 2019 | Up-regulation of miRNA-105 inhibits the progression of gastric carcinoma by directly targeting SOX9. | 3 |
| 31364116 | 2019 | MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9. | 10 |
| 29662176 | 2018 | Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. | 219 |
Citation
Dessen P
MIR105-2 (microRNA 105-2)
Atlas Genet Cytogenet Oncol Haematol. 2014-09-01
Online version: http://atlasgeneticsoncology.org/gene/54894/mir105-2-(microrna-105-2)
